It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 04617cam 2200877 a 4500
001 ocm08928639
003 OCoLC
005 20201001202147.0
008 821020s1983 nyua b 101 0 eng
010 $a 82019001
040 $aDLC$beng$cDLC$dNLM$dUKM$dMUQ$dBAKER$dBTCTA$dYDXCP$dGEBAY$dBDX$dOCLCF$dWUM$dDEBBG$dOCLCO$dOCLCA$dOCLCQ$dOCLCO$dOCLCA$dBGU$dOCLCO$dCNO$dOCLCO$dOCLCA
015 $aGB8328368$2bnb
016 7 $a8217458$2DNLM
019 $a8907957$a16586078$a1058329568$a1091856986
020 $a0306411938
020 $a9780306411939
035 $a(OCoLC)8928639$z(OCoLC)8907957$z(OCoLC)16586078$z(OCoLC)1058329568$z(OCoLC)1091856986
050 00 $aQP671.P6$bP67 1981
060 00 $aW1$bAD559 v.160 1983
060 10 $aQU 110$bP836p 1981
082 00 $a616.99/406$219
084 $aWD 5380$2rvk
111 2 $aPorphyrin Photosensitization Workshop$d(1981 :$cWashington, D.C.)
245 10 $aPorphyrin photosensitization /$cedited by David Kessel and Thomas J. Dougherty.
260 $aNew York :$bPlenum Press,$c©1983.
300 $aix, 294 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aAdvances in experimental medicine and biology ;$vv. 160
500 $a"Proceedings of a Porphyrin Photosensitization Workshop, held September 28-29, 1981, in Washington, D.C."--Title page verso.
504 $aIncludes bibliographical references and index.
520 $aThis book contains contributions from participants at a Porphyrin Photosensitization Workshop held in Washington DC on 28-29 September, 1981. There had been several prior such gathering during 1979 and 1980, but the 1981 meeting was the most extensive to date with almost 200 attending. These periodic meeting are designed to enable workers in the field to exchange information and learn of recent developments. The workshop was supported by PHS grant CA 31188 awarded by the National Cancer Institute, DHHS. Additional funds from Coherent Inc. [Laser Division], Palo Alton, contributed to the success of this meeting as did the many excellent presentation and discussions. Preparation of camera-ready copy from submitted manuscripts was carried out via the Textedit computer program by Glenn Cummings, Amanda Cummings and David Kessel. Responsibility for final manuuscript preparation rests with the editors.
650 0 $aPorphyrins$xPhysiological effect$vCongresses.
650 0 $aPhotosensitization, Biological$vCongresses.
650 0 $aPhotochemotherapy$vCongresses.
650 2 $aPhotochemotherapy$xmethods.$0https://id.nlm.nih.gov/mesh/D010778Q000379
650 2 $aPorphyrins$xpharmacology.$0https://id.nlm.nih.gov/mesh/D011166Q000494
650 2 $aPorphyrins$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D011166Q000627
650 6 $aPorphyrines$xEffets physiologiques$xCongrès.
650 6 $aPhotosensibilisation (Biologie)$xCongrès.
650 6 $aPhotochimiothérapie$xCongrès.
650 7 $aPhotochemotherapy.$2fast$0(OCoLC)fst01061521
650 7 $aPhotosensitization, Biological.$2fast$0(OCoLC)fst01062104
650 7 $aPorphyrins$xPhysiological effect.$2fast$0(OCoLC)fst01071939
650 7 $aFotochemotherapie$2gnd
650 7 $aPhotosensibilisierung$gMedizin$2gnd
650 7 $aPorphyrine$2gnd
650 7 $aKongress$2gnd
650 07 $aPorphyrine.$2swd
650 07 $aPhotosensibilisierung (Medizin)$2swd
650 07 $aKongress.$2swd
650 07 $aPhotochemotherapie.$2swd
653 $aMan$aCancer$aPhotoradiotherapy$aUse of porphyrins
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
655 4 $aKongress$zWashington (DC)$y1981.
655 4 $aPhotosensibiliserung.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 7 $aKonferenzschrift$y1981$zWashington DC.$0(DE-588)1071861417.$2gnd
700 1 $aKessel, David.
700 1 $aDougherty, Thomas J.$q(Thomas John),$d1933-
830 0 $aAdvances in experimental medicine and biology ;$vv. 160.
938 $aBaker & Taylor$bBKTY$c129.00$d129.00$i0306411938$n0000759539$sactive
938 $aBrodart$bBROD$n33731187$c$49.50
938 $aBaker and Taylor$bBTCP$n82019001
938 $aYBP Library Services$bYANK$n167805
029 1 $aAU@$b000002358005
029 1 $aDEBBG$bBV000095598
029 1 $aGBVCP$b013906445
029 1 $aGEBAY$b231333
029 1 $aNLGGC$b830621210
029 1 $aNLM$b8217458
029 1 $aNZ1$b135140
029 1 $aNZ1$b2572586
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 257 OTHER HOLDINGS